Tetrakok

Roman name

Tetracoq

The composition and the form of

In one dose (05 ml) adsorbed vaccine to prevent diphtheria, tetanus, whooping cough and polio is purified difterinogo one toxoid vaccine dose purified tetanus toxoid vaccine, 1 dose bordetella pertussis least 4 IU, inactivated vaccine to prevent polio 1st type 1 vaccine dose inactivated vaccine to prevent polio II type 1 vaccine dose of inactivated vaccine to prevent polio third type 1 vaccine dose, aluminium hydroxide in terms of the Al maximum of 1.25 mg, formaldehyde than 0.1 mg, 2-fenoletanola maximum 0,005 ml; in the injection of one dose, in a package 1 and 20 pcs. ; in vials to 10 or 20 doses, in a package 10 pcs. One vaccine dose difterinogo toxoid with at least 30 IU, when measuring protectivna activity in parallel with the standard WHO or other standard ottitrovannom in accordance with the international standard. One vaccine dose of tetanus toxoid with at least 60 IU measured protectivna activity in parallel with the standard WHO or other standard ottitrovannam in accordance with the international standard. One dose of inactivated vaccine to prevent polio types 1, 2 and 3 corresponds to the number of antigen satisfactory standards test flocks activity described in the French and European farmakopeah.

Of drugs

The vaccine is made from difterinogo and tetanus toxins, inactivated formalin and cleaned, kokluschnykh sticks subjected to thermal inactivation, and the three types of polio virus, cultivated on the line VERO cells and inactivated formalin. Immunity acquired after the second injection vaccines increases with the product introductions and continued for at least 5 years after the first hour.

Directory → Immunotropona funds → Vaccines, serums, fagi → Tetrakok

Tetrakok

Roman name

The composition and the form of

Of drugs

Storage conditions

Shelf life

The registration

All products of this group